Budget Impact Analysis And Long-Term Disease Implications Of Hepatitis C Treatments In Sweden.

@article{Neovius2015BudgetIA,
  title={Budget Impact Analysis And Long-Term Disease Implications Of Hepatitis C Treatments In Sweden.},
  author={K. Neovius and J. S{\"o}derholm and K. B{\"u}sch},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2015},
  volume={18 7},
  pages={
          A581
        }
}
  • K. Neovius, J. Söderholm, K. Büsch
  • Published 2015
  • Medicine
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Figure 4. Cost per cure for cirrhotic genotype 1 patients (by treatment regime) Hepatitis C Virus (HCV) is a global health problem with over 170 million people with a chronic HCV infection.1 Depending on the genetic differences, HCV is grouped into six genotypes with around half of the Swedish patients being infected with genotype 1. In Sweden the prevalence of chronic HCV is 0.36%, which corresponds to approximately 35 000 patients.2 The standard of care was, until 2011, 48 weeks of weekly… Expand

References

SHOWING 1-2 OF 2 REFERENCES
Läkemedelsbehandling av hepatit C-virusinfektion hos vuxna och barn [Internet
  • 2015
Prevalence of Hepatitis C and presence
  • 2011